- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07680387
Sympathetic Nerve Activity and Strength Gains in Resistance Versus Concurrent Training (SKNA-CT)
June 25, 2026 updated by: Beijing Sport University
Sympathetic Activation and Strength Gains Rise Together Under Resistance Training But Uncouple Under Concurrent Training: An 8-Week Randomized Controlled Trial in Untrained Men
This study examines how the body's stress (sympathetic) nervous system responds to 8 weeks of either strength training alone or strength training combined with endurance (treadmill running) training in previously untrained young men.
Skin sympathetic nerve activity, a noninvasive marker of sympathetic nervous system activity, is measured before and after training, along with muscle strength, jumping ability, and heart rate variability.
The study investigates whether changes in sympathetic nervous system activity are associated with changes in strength and jumping ability, and whether this relationship differs between men who perform strength training alone versus those who combine strength and endurance training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study examined how the body's stress (sympathetic) nervous system responds to 8 weeks of either strength training alone or strength training combined with endurance (treadmill running) training in previously untrained young men.
Skin sympathetic nerve activity, a noninvasive marker of sympathetic nervous system activity, was measured before and after training, along with muscle strength, jumping ability, and heart rate variability.
The study found that in men who did strength training only, those whose sympathetic nervous system activity increased the most also gained the most strength and jumping ability.
This relationship was not seen, and in some cases reversed, in men who combined strength training with endurance training.
The findings suggest that adding endurance exercise changes how the nervous system adapts to a strength training program, alongside the well-documented reduction in strength gains seen with combined training (the "interference effect").
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100091
- Beijing sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy young men
- No hypertension or cardiovascular/vascular disease
- No migraine or neurodegenerative disease
- No smoking or alcohol use
- No prior structured exercise training
- No musculoskeletal injury
- Willing to abstain from caffeine, alcohol, and strenuous exercise for 24 hours before testing
Exclusion Criteria:
- Hypertension or cardiovascular/vascular disease
- Migraine or neurodegenerative disease
- Current smoking or alcohol use
- Prior structured exercise training history
- Musculoskeletal injury precluding resistance or endurance exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Strength-only training
Participants performed a supervised resistance training program three times weekly for 8 weeks: weighted calf raises (80% 1RM, 4x6), back squats (75% 1RM, 4x6), countermovement jumps (60-cm target height, 4x6), and weighted lunges (60% 1RM, 4x5), using a Smith machine.
|
Supervised resistance exercise comprising weighted calf raises, back squats, countermovement jumps, and weighted lunges, performed on a Smith machine three times weekly for 8 weeks.
|
|
Experimental: Concurrent training
Participants performed the identical resistance training program as the Strength-only arm, followed by 30-40 minutes of moderate-intensity treadmill running (46-64% VO2max) once heart rate had returned to 40% of maximum, three times weekly for 8 weeks (a strength-priority exercise sequence).
|
performed on a Smith machine three times weekly for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
skin sympathetic nerve activity (aSKNA)
Time Frame: Baseline and 8 weeks
|
Average rectified voltage of skin sympathetic nerve activity recorded noninvasively via the neuECG method.
|
Baseline and 8 weeks
|
|
Change in one-repetition maximum (1RM) back squat
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
|
Change in countermovement jump (CMJ) height
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in CMJ peak velocity
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Change in CMJ peak power
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Change in SKNA burst duration
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Change in SKNA burst amplitude
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Change in SKNA burst total area
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Change in CMJ peak force
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2024
Primary Completion (Actual)
December 12, 2024
Study Completion (Actual)
December 13, 2024
Study Registration Dates
First Submitted
June 22, 2026
First Submitted That Met QC Criteria
June 25, 2026
First Posted (Actual)
July 2, 2026
Study Record Updates
Last Update Posted (Actual)
July 2, 2026
Last Update Submitted That Met QC Criteria
June 25, 2026
Last Verified
September 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BSU-2024224H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual participant data that underlie the results reported in this article will be made available upon reasonable request to the corresponding author.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sympathetic Nervous System
-
Tianjin Medical UniversityTianjin Medical University General HospitalRecruitingSympathetic Nervous System Diseases | Sympathetic Nervous Structure Injury | Sympathetic Nerve InjuryChina
-
Air Liquide Santé InternationalCompleted
-
Seoul National University HospitalRecruitingFusion of Spine | Sympathetic Nervous SystemKorea, Republic of
-
University of Missouri-ColumbiaAmerican Heart Association (AHA)RecruitingAging | Blood Flow | Women | Sympathetic Nervous SystemUnited States
-
Eric Grouzmanngrégoire millet; grégoire wuerzner; Nicolas Bourdillon; Philippe EugsterCompletedPhysical Activity | Sympathetic Nervous System | Secretion; CatecholamineSwitzerland
-
Superior UniversityActive, not recruitingEffectiveness of DT vs GMIT on Wrist Pain and Function in Patients With Reflex Sympathetic DystrophySympathetic; DystrophyPakistan
-
Université Catholique de LouvainErasme University HospitalUnknownHeart Rate Variability | Autonomic Nervous System | Muscle Sympathetic Nerve ActivityBelgium
-
Royal Perth HospitalCompletedCentral Sympathetic Nervous System DiseasesAustralia
-
University Hospital, AngersCompletedDysautonomia | Sympathetic Nervous System | ACCUVEIN | Superficial Veins | Standing TestFrance
-
Stichting Achmea Slachtoffer en SamenlevingCompletedRSD (Reflex Sympathetic Dystrophy) | Algodystrophy | CRPS Type INetherlands
Clinical Trials on Strength-only training
-
Riphah International UniversityCompletedPatellofemoral PainPakistan
-
University of FloridaCompleted
-
University of AarhusUnknownOsteoarthritis, KneeDenmark
-
Universidad Autónoma de Manizales, ColombiaCompletedFemale | Volleyball | PlayerColombia
-
Norwegian University of Science and TechnologyCompleted
-
University of VigoNot yet recruitingPatients | Cancer Survivors | NeoplamsSpain
-
Christian DallCompletedHeart Failure | Ischemic Heart Disease | Heart Transplant RecipientsDenmark
-
Lislei Jorge PatrizziCompleted
-
Eunice Kennedy Shriver National Institute of Child...Shriners Hospitals for Children; University of DelawareUnknownSpastic Diplegic Cerebral PalsyUnited States
-
Isra UniversityCompleted